Summary
134.83 -3.89(-2.80%)07/02/2024
Inspire Medical Systems Inc (INSP)
Inspire Medical Systems Inc (INSP)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -2.80 | -3.28 | -9.21 | -34.25 | -28.22 | -57.81 | 118.09 | 439.73 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 134.83 | |
| Open | 139.17 | |
| High | 139.74 | |
| Low | 133.59 | |
| Volume | 311,757 | |
| Change | -3.89 | |
| Change % | -2.80 | |
| Avg Volume (20 Days) | 714,845 | |
| Volume/Avg Volume (20 Days) Ratio | 0.44 | |
| 52 Week Range | 123.27 - 329.99 | |
| Price vs 52 Week High | -59.14% | |
| Price vs 52 Week Low | 9.37% | |
| Range | -3.12 | |
| Gap Up/Down | -0.83 | |
Fundamentals | ||
| Market Capitalization (Mln) | 4,121 | |
| EBIDTA | -26,085,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 305.11 | |
| Book Value | 8.0550 | |
| Earnings Per Share | -1.7350 | |
| EPS Estimate Current Quarter | -0.6100 | |
| EPS Estimate Next Quarter | -0.5700 | |
| EPS Estimate Current Year | -1.9700 | |
| EPS Estimate Next Year | -1.6900 | |
| Diluted EPS (TTM) | -1.7350 | |
| Revenues | ||
| Profit Marging | -0.2345 | |
| Operating Marging (TTM) | -0.2243 | |
| Return on asset (TTM) | -0.1024 | |
| Return on equity (TTM) | -0.2099 | |
| Revenue TTM | 201,004,992 | |
| Revenue per share TTM | 7.3990 | |
| Quarterly Revenue Growth (YOY) | 0.7210 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 97,758,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 27.3221 | |
| Revenue Enterprise Value | 29.0534 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 27,358,100 | |
| Shares Float | 26,797,258 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 2.15 | |
| Institutions (%) | 96.19 | |
07/02 08:00 EST - globenewswire.com
Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024
MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024
MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
06/06 12:36 EST - zacks.com
Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
06/04 08:00 EST - globenewswire.com
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Medtech Conference on Tuesday, June 18, 2024.
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Medtech Conference on Tuesday, June 18, 2024.
05/28 06:00 EST - investorplace.com
7 Undervalued Stocks That Could Triple Your Money by 2026
Buying the dips and acquiring shares of a proven company on short-term declines has been a successful strategy over the long-term. When investors look back five or 10 years from now, the opportunities which presented themselves during the Great Recession, the COVID trough, or even the recent downturn in 2022 were worth buying.
7 Undervalued Stocks That Could Triple Your Money by 2026
Buying the dips and acquiring shares of a proven company on short-term declines has been a successful strategy over the long-term. When investors look back five or 10 years from now, the opportunities which presented themselves during the Great Recession, the COVID trough, or even the recent downturn in 2022 were worth buying.
05/23 08:00 EST - globenewswire.com
Inspire Medical Systems, Inc. to Present at the Jefferies Global Healthcare Conference
MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024.
Inspire Medical Systems, Inc. to Present at the Jefferies Global Healthcare Conference
MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024.
05/21 13:40 EST - zacks.com
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
05/09 10:36 EST - zacks.com
Inspire (INSP) Loses -31.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Inspire (INSP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Inspire (INSP) Loses -31.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Inspire (INSP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
05/08 12:36 EST - zacks.com
Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
05/08 10:36 EST - zacks.com
Inspire (INSP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Inspire (INSP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05/07 22:38 EST - seekingalpha.com
Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference Call Participants Danielle Antalffy - UBS Travis Steed - Bank of America Adam Maeder - Piper Sandler Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Anthony Petrone - Mizuho Chris Pasquale - Nephron Richard Newitter - Truist Securities Shagun Singh - RBC John Block - Stifel Mike Kratky - Leerink Partners Michael Sarcone - Jefferies Larry Biegelsen - Wells Fargo Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer Operator Good afternoon. My name is [Dilem], and I'll be your conference operator today.
Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference Call Participants Danielle Antalffy - UBS Travis Steed - Bank of America Adam Maeder - Piper Sandler Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Anthony Petrone - Mizuho Chris Pasquale - Nephron Richard Newitter - Truist Securities Shagun Singh - RBC John Block - Stifel Mike Kratky - Leerink Partners Michael Sarcone - Jefferies Larry Biegelsen - Wells Fargo Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer Operator Good afternoon. My name is [Dilem], and I'll be your conference operator today.
05/07 18:11 EST - zacks.com
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.53 per share a year ago.
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.53 per share a year ago.
05/07 16:02 EST - globenewswire.com
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
Inspire Reports Year-over-Year Revenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
Inspire Reports Year-over-Year Revenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024
05/03 10:21 EST - zacks.com
Gear Up for Inspire (INSP) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Inspire (INSP) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Gear Up for Inspire (INSP) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Inspire (INSP) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
04/30 08:00 EST - globenewswire.com
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.
04/18 13:21 EST - zacks.com
Why You Should Add Inspire Medical (INSP) to Your Portfolio
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Why You Should Add Inspire Medical (INSP) to Your Portfolio
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
04/18 03:16 EST - zacks.com
Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
04/09 12:33 EST - headlinesoftoday.com
InspireSemi Announces Final Closing of Private Placement
VANCOUVER, British Columbia and AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“InspireSemi” or the “Company”), a chip design company that provides revolutionary high-performance, energy-efficient accelerated computing solutions for High Performance Computing (HPC), AI, graph analytics, and other compute-intensive workloads, today announced, further to its press release dated April 1, … The post InspireSemi Announces Final Closing of Private Pl...
InspireSemi Announces Final Closing of Private Placement
VANCOUVER, British Columbia and AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“InspireSemi” or the “Company”), a chip design company that provides revolutionary high-performance, energy-efficient accelerated computing solutions for High Performance Computing (HPC), AI, graph analytics, and other compute-intensive workloads, today announced, further to its press release dated April 1, … The post InspireSemi Announces Final Closing of Private Pl...
04/09 07:16 EST - zacks.com
New Strong Buy Stocks for April 9th
SRDX, X, TELNY, INSP and MTAL have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2023.
New Strong Buy Stocks for April 9th
SRDX, X, TELNY, INSP and MTAL have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2023.
04/02 08:00 EST - globenewswire.com
Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2024 after the close of trading on Tuesday, May 7. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2024 after the close of trading on Tuesday, May 7. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
03/20 15:01 EST - zacks.com
3 Medical Info Systems Stocks to Buy as Industry Improves
A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.
3 Medical Info Systems Stocks to Buy as Industry Improves
A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.